References
- Netherlands Reference Laboratory for Bacterial Meningitis. Bacterial meningitis in the Netherlands; annual reports 1980–1992. Universiteit van Amsterdam, Amsterdam 1981–1993
- Peltola H. Meningococcal disease: still with us. Rev Infect Dis 1983; 5: 71–91
- Schwartz B, Moore PS, Broome CV. Global epidemiology of meningococcal disease. Clin Microbiol Rev 1989; 2(Suppl)S118–S124
- Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children, a meta-analysis. Pediatr Infect Dis J 1993; 12: 389–394
- Havens PL, Garland JS, Brook MM, Dewitz BA, Stremski ES, Troshynski TJ. Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987. Pediatr Infect Dis J 1989; 8: 8–11
- Scholten R JPM, Bijlmer HA, Poolman JT, Kuipers B, Caugant DA, Van Alphen A JW, Dankert J, Valkenburg HA. Meningococcal disease in the Netherlands, 1958–1990. A steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin Infect Dis 1993; 16: 237–246
- Scholten R JPM, Bijlmer HA, Valkenburg HA, Dankert J. Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis. Epidemiol Infect 1994; 112: 115–124
- Scholten R JPM, Kuipers B, Valkenburg HA, Dankert J, Zollinger WD, Poolman JT. Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J Med Microbiol 1994; 41: 236–243
- Spanjaard L, Bol P, Ekker W, Zanen HC. The incidence of bacterial meningitis in the Netherlands: a comparison of three registration systems, 1977–1982. J Infect 1985; 11: 259–268
- Goldschneider I, Gotschlich EC, Artenstein RS. Human immunity to the meningococcus. II. Development of natural immunitiy. J Exp Med 1969; 129: 1327–1348
- Bohr V, Hansen B, Jessen O, Johnsen N, Kjersem H, Kristensen HS, Nyboe J, Rasmussen N. Eight hundred and seventy-five cases of bacterial meningitis. Part I of a three-part series: Clinical data, prognosis, and the role of specialised hospital departments. J Infect 1983; 7: 21–30
- Swart AG, Fijen C AP, Te Bulte MT, Daha MR, Dankert J, Kuijper EJ. Complement deficienties en meningokokkenziekte in Nederland. Ned Tijdschr Geneeskd 1993; 137: 1147–1152
- Anonymous. Drugs for the doctor's bag. Drug Ther Bull 1989; 27: 17–19
- Halstensen A, Pedersen S HJ, Haneberg B, Bjorvatn B, Solberg CO. Case fatality of meningococcal disease in Western Norway. Scand J Infect Dis 1987; 19: 35–42
- Borchsenius F, Bruun JN, Tønjum T. Systemic meningococcal disease: the diagnosis on admission to hospital. NIPH Ann 1991; 14: 11–22
- Spanjaard L, Bol P, De Marie S, Zanen HC. Association of meningococcal serogroups with the course of disease in the Netherlands, 1959–83. Bull WHO 1987; 65: 861–868
- Palmer SR, Corson J, Hall R, Payne S, Ludlow J, Deere B, Jones H, Kaul S, Stubbins J, Williams R, Walapu M. Spence A, Jenkins P, Donald D. Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect 1992; 25: 321–328
- Samuelsson S, Ege P, Berthelsen B, Lind I. An outbreak of serogroup B:15:P1.16 meningococcal disease, Frederiksborg County, Denmark, 1987–9. Epidemiol Infect 1992; 108: 19–30
- Tüysüz B, Özlü I, Aji DY, Erginel A. Prognostic factors in meningococcal disease and a new scoring system. Acta Pediatr Scand 1993; 82: 1053–1056
- Naess A, Halstensen A, Nyland H, Pedersen S HJ, Møller P, Borgmann R, Larsen JL, Haga E. Sequelae one year after meningococcal disease. Acta Neurol Scand 1994; 89: 139–142